BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen SMY, Krinsky AL, Woolaver RA, Wang X, Chen Z, Wang JH. Tumor immune microenvironment in head and neck cancers. Mol Carcinog 2020;59:766-74. [PMID: 32017286 DOI: 10.1002/mc.23162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Feng B, Hess J. Immune-Related Mutational Landscape and Gene Signatures: Prognostic Value and Therapeutic Impact for Head and Neck Cancer. Cancers (Basel) 2021;13:1162. [PMID: 33800421 DOI: 10.3390/cancers13051162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Takahashi H, Kawabata-Iwakawa R, Ida S, Mito I, Tada H, Chikamatsu K. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma. Sci Rep 2021;11:17789. [PMID: 34493792 DOI: 10.1038/s41598-021-97292-6] [Reference Citation Analysis]
3 Wang L, Yang G, Liu G, Pan Y. Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma. Front Pharmacol 2021;12:795205. [PMID: 35242027 DOI: 10.3389/fphar.2021.795205] [Reference Citation Analysis]
4 Mito I, Takahashi H, Kawabata-Iwakawa R, Ida S, Tada H, Chikamatsu K. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma. Sci Rep 2021;11:16134. [PMID: 34373557 DOI: 10.1038/s41598-021-95718-9] [Reference Citation Analysis]
5 Ida S, Takahashi H, Kawabata-Iwakawa R, Mito I, Tada H, Chikamatsu K. Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma. Oral Oncol 2021;122:105508. [PMID: 34507204 DOI: 10.1016/j.oraloncology.2021.105508] [Reference Citation Analysis]
6 Lu YC, Wang XJ. Harnessing the power of the immune system in cancer immunotherapy and cancer prevention. Mol Carcinog 2020;59:675-8. [PMID: 32386070 DOI: 10.1002/mc.23211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang JH. Why the Outcome of Anti-Tumor Immune Responses is Heterogeneous: A Novel Idea in the Context of Immunological Heterogeneity in Cancers. Bioessays 2020;42:e2000024. [PMID: 32767371 DOI: 10.1002/bies.202000024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhang Y, Chen P, Zhou Q, Wang H, Hua Q, Wang J, Zhong H. A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma. Front Genet 2021;12:570336. [PMID: 34220923 DOI: 10.3389/fgene.2021.570336] [Reference Citation Analysis]
9 Woolaver RA, Wang X, Krinsky AL, Waschke BC, Chen SMY, Popolizio V, Nicklawsky AG, Gao D, Chen Z, Jimeno A, Wang XJ, Wang JH. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts. J Immunother Cancer 2021;9:e001615. [PMID: 33414263 DOI: 10.1136/jitc-2020-001615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Gül D, Schweitzer A, Khamis A, Knauer SK, Ding GB, Freudelsperger L, Karampinis I, Strieth S, Hagemann J, Stauber RH. Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer. Cancers (Basel) 2022;14:2337. [PMID: 35565465 DOI: 10.3390/cancers14092337] [Reference Citation Analysis]
11 Lv D, Chen J, Kang Y, Luo M, Chen H, Cui B, Wang L, Wang J, Zhou X, Feng Y, Huang L, Zhang P. Protein Kinase D3 Promotes the Reconstruction of OSCC Immune Escape Niche Via Regulating MHC-I and Immune Inhibit Molecules Expression. J Immunother 2021;44:339-47. [PMID: 34545012 DOI: 10.1097/CJI.0000000000000395] [Reference Citation Analysis]
12 Takahashi H, Rokudai S, Kawabata-Iwakawa R, Sakakura K, Oyama T, Nishiyama M, Chikamatsu K. AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:1233. [PMID: 33799788 DOI: 10.3390/cancers13061233] [Reference Citation Analysis]
13 Zhu Y, Zheng S, Zhai X, Wang C, Liu A, Ju J, Peng X, Chen L, Zhang Y, Ren N, Xie Y, Fan J, Zhao K, Liu M, Zhuo Z. Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck. Journal of Immunology Research 2022;2022:1-16. [DOI: 10.1155/2022/5501476] [Reference Citation Analysis]
14 Xu Q, Fang M, Zhu J, Dong H, Cao J, Yan L, Leonard F, Oppel F, Sudhoff H, Kaufmann AM, Albers AE, Qian X. Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck. Int J Biol Sci 2020;16:2506-17. [PMID: 32792853 DOI: 10.7150/ijbs.47068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang Z, Zhang H, Zhai Y, Li F, Shi X, Ying M. Single-Cell Profiling Reveals Heterogeneity of Primary and Lymph Node Metastatic Tumors and Immune Cell Populations and Discovers Important Prognostic Significance of CCDC43 in Oral Squamous Cell Carcinoma. Front Immunol 2022;13:843322. [DOI: 10.3389/fimmu.2022.843322] [Reference Citation Analysis]
16 Chen SMY, Li B, Nicklawsky AG, Krinsky AL, Brunetti T, Woolaver RA, Wang X, Chen Z, Young CD, Gao D, Wang XJ, Wang JH. Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E6585. [PMID: 32916850 DOI: 10.3390/ijms21186585] [Reference Citation Analysis]
17 Qiao B, Chen Z, Huang J, King-Yin Lam A, Mei Z, Li Y, Qiao J. LBP as a biomarker in oral and maxillofacial tumors. Oral Dis 2021. [PMID: 34653303 DOI: 10.1111/odi.14042] [Reference Citation Analysis]
18 Fan C, Wu J, Shen Y, Hu H, Wang Q, Mao Y, Ye B, Xiang M. Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma. Cancer Med 2021. [PMID: 34964283 DOI: 10.1002/cam4.4511] [Reference Citation Analysis]
19 Takahashi H, Sakakura K, Ida S, Kawabata-Iwakawa R, Matsuyama T, Tada H, Mito I, Chikamatsu K. Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma. Cancer Sci 2021. [PMID: 34751489 DOI: 10.1111/cas.15195] [Reference Citation Analysis]
20 Fan C, Hu H, Shen Y, Wang Q, Mao Y, Ye B, Xiang M. PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma. Transl Oncol 2021;14:101042. [PMID: 33618069 DOI: 10.1016/j.tranon.2021.101042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Kozłowska J, Kolenda T, Poter P, Sobocińska J, Guglas K, Stasiak M, Bliźniak R, Teresiak A, Lamperska K. Long Intergenic Non-Coding RNAs in HNSCC: From "Junk DNA" to Important Prognostic Factor. Cancers (Basel) 2021;13:2949. [PMID: 34204634 DOI: 10.3390/cancers13122949] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Mat Lazim N, Elliott M, Wykes J, Clark J. Oligometastases in head and neck carcinoma and their impact on management. ANZ J Surg 2021. [PMID: 33634950 DOI: 10.1111/ans.16622] [Reference Citation Analysis]
23 Nguyen KA, Keith MJ, Keysar SB, Hall SC, Bimali A, Jimeno A, Wang XJ, Young CD. Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell-like properties and phosphoinositide 3-kinase inhibitor insensitivity. Mol Carcinog 2022. [PMID: 35417043 DOI: 10.1002/mc.23409] [Reference Citation Analysis]